Overview

Interferon Lambda Therapy for COVID-19

Status:
Withdrawn

Trial end date:
2021-02-05

Target enrollment:

Participant gender:

Summary

The main purpose of this research study is to test the safety and effectiveness of an investigational drug peginterferon lambda-1a in treating COVID-19.

Phase:

Phase 2

Details

Lead Sponsor:

Icahn School of Medicine at Mount Sinai

Collaborator:

Eiger BioPharmaceuticals

Treatments:

Interferons